Skip to main content
. Author manuscript; available in PMC: 2016 Jul 27.
Published in final edited form as: JAMA Neurol. 2013 Dec;70(12):1512–1519. doi: 10.1001/jamaneurol.2013.4013

Figure 2. Degree and Topographic Distribution of Neurodegenerative Abnormalities in the Berkley Aging Cohort (BAC) Cognitively Normal (NC) Cases.

Figure 2

A and C, For cortical thickness, fludeoxyglucose positron emission tomography (FDG-PET), and hippocampal volume (HV), degree of neurodegenerative abnormality within the Alzheimer disease (AD) region of interest (ROI) (A) and topographic specificity (C) are depicted for biomarker normal and abnormal BAC NC cases and Alzheimer's Disease Neuroimaging Initiative (ADNI) AD cases. B, Cortexwide comparisons between normal and abnormal BAC NC cases. cThick indicates cortical thickness and NS, not significant.

aP < .001.

bP < .05.

cP < .01.